Magenta Therapeutics’ Stem Cell Therapy MGTA-456 Earns FDA’s Regenerative Medicine Advanced Therapy Designation

News

The U.S. Food and Drug Administration (FDA) has granted Magenta Therapeutics’ cell therapy MGTA-456 the Regenerative Medicine Advanced Therapy (RMAT) designation for treating inherited metabolic disorders, including cerebral adrenoleukodystrophy. The RMAT designation ... Read more

February 1, 2019February 1, 2019

Abnormalities in Bile Acid Production Found in Patient with X-linked ALD, Case Study Reports

News

Abnormalities in the production of bile acid — an acid produced by the liver that is responsible for the digestion of dietary fats — were described for the first time ... Read more

Posts by: Iqra Mumal

Iqra Mumal

Magenta Therapeutics’ Stem Cell Therapy MGTA-456 Earns FDA’s Regenerative Medicine Advanced Therapy Designation

Abnormalities in Bile Acid Production Found in Patient with X-linked ALD, Case Study Reports